Nephrodite Wins FDA Breakthrough Device Designation for “Holly”

This investigational implantable, continuous dialysis device has completed its first large animal trials. The company plans to do Good Laboratory Practice studies followed by applying to regulators for first-in-human clinical trials.

Read the full article » | Posted 01-16-2026

Related Articles

• Xeltis is Trialing its Polymer-based Vascular Access Posted 03-12-2026
• New Bluetooth-enabled CAPD System Enhanced Patient Satisfaction Posted 03-12-2026
• Emerging Biomarker Research in PD Posted 03-12-2026
• Byonyks’ X1 APD Cycler Received FDA 510(k) Approval Last Summer Posted 02-17-2026